Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K213849
    Date Cleared
    2022-03-09

    (89 days)

    Product Code
    Regulation Number
    882.1870
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The SafeOp 2: Neural Informatix System is intended for use in monitoring neurological status by recording somatosensory evoked potentials (SSEP), electromyography (EMG), or assessing the neuromuscular junction (NMJ). Neuromonitoring procedures include intracranial, intratemporal, extratemporal, neck dissections, upper and lower extremities, spinal degenerative treatments, pedicle screw fixation, intervertebral fusion cages, rhizotomy, orthopedic surgery, open/percutaneous, lumbar, thoracic, and cervical surgical procedures.

    Device Description

    The SafeOp™ 2: Neural Informatix System (SafeOp 2 System), formerly known as EPAD 2 (K182542), consists of the SafeOp head unit with power supply and IV pole mount, the Alpha Informatix Tablet with docking station and power supply and a data transfer USB cable. Associated disposable accessories consists of an electrode harness, surface and/or subdermal needle electrodes, and stimulating probe or clip contained in various kits. The SafeOp 2 System head unit contains a complete data acquisition system that has builtin stimulators, amplifiers, relays, A/D Converters, Digital Signal Processors, CPUs, and storage devices. The head unit interfaces with other equipment through communication ports and serves as the patient-contacting portion of the system where it is close to the surgical field. The head unit hardware contains an eight acquisition (input) channel and six-output channel Evoked Potential Stimulator that is used in the operating room to display nerve and muscle responses. The user can use these responses to diagnose insults to the peripheral or central nerves and to determine relative nerve location, proximity, and integrity data. The SafeOp 2 System application provides the primary graphical user interface and controls for the SafeOp 2 System. The application runs on a touchscreen tablet mobile device which connects to the head unit either via wired USB cable or wireless via Wi-Fi, enabling both user input (e.g., patient and procedure information, adjustment of stimulus and acquisition parameters) and display of output (e.g., display of acquired waveforms, data, messages and alerts to the clinician).

    AI/ML Overview

    The provided text is a 510(k) summary for the SafeOp 2: Neural Informatix System. It primarily focuses on demonstrating substantial equivalence to a predicate device (EPAD™ 2 System, K182542) rather than presenting a detailed study proving the device meets specific acceptance criteria based on clinical performance.

    Here's a breakdown of the requested information based on the provided text:

    1. Table of acceptance criteria and the reported device performance

    The document does not explicitly state quantitative "acceptance criteria" and "reported device performance" in the typical sense of a clinical study measuring diagnostic accuracy or treatment efficacy. Instead, it demonstrates "substantial equivalence" to a predicate device by comparing various specifications. The "acceptance criteria" for this submission would broadly be that the device's specifications and performance are comparable to the predicate, with any differences not introducing new safety or effectiveness concerns.

    Specification/PropertyPredicate Device (EPAD™ 2 System, K182542)Subject Device (SafeOp™ 2 System)Performance/Rationale
    Intended Use/Indications for UseIdenticalIdenticalIdentical
    Device ClassIIIIIdentical
    Product CodeGWF, GXY, GXZ, IKN, PDQ, ETNGWF, GXY, GXZ, IKN, PDQ, ETNIdentical
    Regulation Number§882.1870, §882.1320, §882.1350, §890.1375, §874.1820, §874.1820§882.1870, §882.1320, §882.1350, §890.1375, §874.1820, §874.1820Identical
    Device Classification NameStimulator, Electrical, Evoked ResponseStimulator, Electrical, Evoked ResponseIdentical
    Monitoring ModalitiesEMG, SSEP, NMJEMG, SSEP, NMJIdentical
    Head Unit Power Supply100 to 240 VAC, 50-60 Hz (input); 15 VDC, 2.5A (output)100 to 240 VAC, 50-60 Hz (input); 12 VDC, 2.5A (output)Head unit power supply does not impact device performance when compared to the predicate. The change in power does not introduce new risks, or impact existing risks. Therefore, this difference does not affect device safety or effectiveness.
    Mode of OperationContinuousContinuousIdentical
    Dimensions12"W x 8"H x 2"D12"W x 8"H x 2"DIdentical
    Weight< 2 lbs< 2 lbsIdentical
    Operating ModesTriggered EMG, Free run EMG, SSEP, NMJTriggered EMG, Free run EMG, SSEP, NMJIdentical
    Total Amplifier ChannelsUp to 8Up to 8Identical
    WaveformMonophasic, RectangularMonophasic, RectangularIdentical
    Pulse Duration50 to 300 µsec300 µsec (SSEP), 200 µsec (EMG)Identical (The provided predicate range encompasses the subject device's specific values, which are typical for each modality, implying no significant difference in capability or safety).
    Frequency (Pulse Rate)0.1 to 50 Hz0.1 to 50 HzIdentical
    Current Range0 to 100 mA0 to 100 mAIdentical
    Input Impedance> 50 MΩ (at DC)> 50 MΩ (at DC)Identical
    Low Frequency Filter10 Hz (SSEP), 30 Hz (EMG)10 Hz (SSEP), 30 Hz (EMG)Identical
    High Frequency Filter2.7 kHz (SSEP & EMG)2.7 kHz (SSEP & EMG)Identical
    Notch Filter50 or 60 Hz50 or 60 HzIdentical
    AlphaInformatix (AIX) Tablet OSAndroid powered tabletWindows 10 powered tabletCompleted V&V testing successfully demonstrates that the differences in the Operating Systems (OS) have no impact on device performance when compared to the predicate. The OS change does not introduce new risks, or impact existing risks. Therefore, this difference does not affect device safety or effectiveness.
    Remote AccessNoNoIdentical
    Surface Electrode Anatomical SitesSSEP: Upper/lower limbs and head/neckSSEP: Upper/lower limbs and head/neckIdentical
    Surface Electrode TypeCustomer cutaneous electrodes for use with SafeOp only. Single, double and triple electrodes.Customer cutaneous electrodes for use with SafeOp only. Single, double and triple electrodes.Identical
    Conductive Surface Area20x25mm25.4x25.4mm (1x1in.)Completed V&V testing successfully demonstrates that the differences in the surface area has no impact on device performance when compared to the predicate. The change does not introduce new risks, or impact existing risks. Therefore, this difference does not affect device safety or effectiveness.
    Conductive GelWet gelSolid gelCompleted V&V testing successfully demonstrates that the differences in the conductive gel has no impact on device performance when compared to the predicate. The change does not introduce new risks, or impact existing risks. Therefore, this difference does not affect device safety or effectiveness.
    ConnectorsNicomatic three pinNicomatic three pinIdentical
    Current Density< 0.75 mArms/cm2< 0.75 mArms/cm2Identical
    SterilityNon-sterile, single patient use, disposableNon-sterile, single patient use, disposableIdentical
    Surface Contact Time≤ 24 hours≤ 24 hoursIdentical
    Other AccessoriesNeedle Electrodes, Stimulating Probes, Cable, ElectrodeNeedle Electrodes, Stimulating Probes, Cable, ElectrodeIdentical
    Biocompatibility (ISO 10993-1)Yes (Tissue/bone/dentin for ≤ 24 hours)Yes (Tissue/bone/dentin for ≤ 24 hours)Identical

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document states: "Determination of substantial equivalence is not based on an assessment of clinical performance data." This indicates that there was no human test set or clinical data involved in proving substantial equivalence for this submission. The evaluation was based on nonclinical performance testing.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    Not applicable, as no human test set or clinical data was used to establish substantial equivalence.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable, as no human test set or clinical data was used to establish substantial equivalence.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. The device is for intraoperative neuromonitoring, not an AI-assisted diagnostic tool that would typically involve a multi-reader multi-case study for diagnostic improvement. The document explicitly states: "Determination of substantial equivalence is not based on an assessment of clinical performance data."

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    The document states that "Nonclinical performance testing demonstrates that the subject SafeOp 2 System meets the functional, system, and software requirements." This indicates that standalone performance testing was conducted for the device's functions (e.g., EMC, electrical safety, usability), but this refers to the system as a whole, not a specific algorithm's performance in isolation from a human user in a diagnostic or interpretive capacity. It does not provide details on the specific performance metrics (e.g., accuracy, sensitivity, specificity) for standalone algorithm performance in interpreting neurological signals.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the nonclinical performance testing (EMC, Electrical Safety, Usability), the ground truth would be based on engineering standards and predetermined functional specifications. For example, for electrical safety, the ground truth is compliance with recognized electrical safety standards (e.g., 60601-1). For usability, the ground truth is that the device "presents no adverse effect within the intended environment."

    8. The sample size for the training set

    Not applicable. The submission is for a neuromonitoring system and does not describe an AI/machine learning model that would require a "training set" in the conventional sense. The "training" here would refer to the development and testing of the engineering system.

    9. How the ground truth for the training set was established

    Not applicable, as there is no mention of a training set for an AI/machine learning model.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1